Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at PDS Biotechnology Corp fell by 17.26m. Cash Flow from Financing totalled 16.38m or -- of revenues. In addition the company used 33.64m for operations while cash used for investing totalled .
Cash flow per share | -1.21 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.8406 |
---|---|
Tangible book value per share | 0.8406 |
More ▼
Balance sheet in USDView more
Current ratio | 3.84 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.7885 |
---|---|
Total debt/total capital | 0.4409 |
More ▼